Cargando…

Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes

OBJECTIVES: Tigecycline is a treatment option for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). Emerging tigecycline resistance in CRKP represents a growing threat. Knowledge of the clinical, microbiological, and molecular characteristics of tigecycline- and carbapenem-resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Sheng-Kang, Chan, Ming-Chin, Huang, Li-Yueh, Lin, Yi-Tsung, Lin, Jung-Chung, Lu, Po-Liang, Siu, L. Kristopher, Chang, Feng-Yee, Yeh, Kuo-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384758/
https://www.ncbi.nlm.nih.gov/pubmed/28388651
http://dx.doi.org/10.1371/journal.pone.0175140
_version_ 1782520498594250752
author Chiu, Sheng-Kang
Chan, Ming-Chin
Huang, Li-Yueh
Lin, Yi-Tsung
Lin, Jung-Chung
Lu, Po-Liang
Siu, L. Kristopher
Chang, Feng-Yee
Yeh, Kuo-Ming
author_facet Chiu, Sheng-Kang
Chan, Ming-Chin
Huang, Li-Yueh
Lin, Yi-Tsung
Lin, Jung-Chung
Lu, Po-Liang
Siu, L. Kristopher
Chang, Feng-Yee
Yeh, Kuo-Ming
author_sort Chiu, Sheng-Kang
collection PubMed
description OBJECTIVES: Tigecycline is a treatment option for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). Emerging tigecycline resistance in CRKP represents a growing threat. Knowledge of the clinical, microbiological, and molecular characteristics of tigecycline- and carbapenem-resistant Klebsiella pneumoniae (TCRKP) is limited. METHODS: Patients infected with TCRKP were identified from a Taiwanese national surveillance study. Clinical data were collected from medical records. We performed susceptibility tests, carbapenemase gene detection, pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Furthermore, we performed quantitative real-time polymerase chain reaction (qRT-PCR) analyses to assess the expression levels of the efflux pump genes acrB and oqxB. RESULTS: We identified 16 patients infected with TCRKP, with urinary tract infection (UTI) being the most common type of infection (63%). The all-cause 30-day mortality rate was 44% in patients with TCRKP infection. Patients with a site of infection other than the urinary tract had a significantly higher mortality rate than patients with UTIs (83% vs. 20%, p = 0.035). PFGE and MLST revealed no dominant clone or sequence type. Using qRT-PCR, overexpression of both the acrB and oqxB genes was identified in seven isolates, and overexpression of the oqxB gene was observed in another seven. There was poor correlation between acrB or oqxB expression and tigecycline MICs (r = -0.038 and -0.166, respectively). CONCLUSIONS: The mortality rate in patients infected with TCRKP in this study was 44% and this is an important subset of patients. The absence of a linear relationship between efflux pump genes expression and MICs indicates that tigecycline resistance may be mediated by other factors. Continuous monitoring of tigecycline resistance among CRKP isolates and resistance mechanisms are necessary.
format Online
Article
Text
id pubmed-5384758
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53847582017-05-03 Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes Chiu, Sheng-Kang Chan, Ming-Chin Huang, Li-Yueh Lin, Yi-Tsung Lin, Jung-Chung Lu, Po-Liang Siu, L. Kristopher Chang, Feng-Yee Yeh, Kuo-Ming PLoS One Research Article OBJECTIVES: Tigecycline is a treatment option for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). Emerging tigecycline resistance in CRKP represents a growing threat. Knowledge of the clinical, microbiological, and molecular characteristics of tigecycline- and carbapenem-resistant Klebsiella pneumoniae (TCRKP) is limited. METHODS: Patients infected with TCRKP were identified from a Taiwanese national surveillance study. Clinical data were collected from medical records. We performed susceptibility tests, carbapenemase gene detection, pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Furthermore, we performed quantitative real-time polymerase chain reaction (qRT-PCR) analyses to assess the expression levels of the efflux pump genes acrB and oqxB. RESULTS: We identified 16 patients infected with TCRKP, with urinary tract infection (UTI) being the most common type of infection (63%). The all-cause 30-day mortality rate was 44% in patients with TCRKP infection. Patients with a site of infection other than the urinary tract had a significantly higher mortality rate than patients with UTIs (83% vs. 20%, p = 0.035). PFGE and MLST revealed no dominant clone or sequence type. Using qRT-PCR, overexpression of both the acrB and oqxB genes was identified in seven isolates, and overexpression of the oqxB gene was observed in another seven. There was poor correlation between acrB or oqxB expression and tigecycline MICs (r = -0.038 and -0.166, respectively). CONCLUSIONS: The mortality rate in patients infected with TCRKP in this study was 44% and this is an important subset of patients. The absence of a linear relationship between efflux pump genes expression and MICs indicates that tigecycline resistance may be mediated by other factors. Continuous monitoring of tigecycline resistance among CRKP isolates and resistance mechanisms are necessary. Public Library of Science 2017-04-07 /pmc/articles/PMC5384758/ /pubmed/28388651 http://dx.doi.org/10.1371/journal.pone.0175140 Text en © 2017 Chiu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Chiu, Sheng-Kang
Chan, Ming-Chin
Huang, Li-Yueh
Lin, Yi-Tsung
Lin, Jung-Chung
Lu, Po-Liang
Siu, L. Kristopher
Chang, Feng-Yee
Yeh, Kuo-Ming
Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes
title Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes
title_full Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes
title_fullStr Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes
title_full_unstemmed Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes
title_short Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes
title_sort tigecycline resistance among carbapenem-resistant klebsiella pneumoniae: clinical characteristics and expression levels of efflux pump genes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384758/
https://www.ncbi.nlm.nih.gov/pubmed/28388651
http://dx.doi.org/10.1371/journal.pone.0175140
work_keys_str_mv AT chiushengkang tigecyclineresistanceamongcarbapenemresistantklebsiellapneumoniaeclinicalcharacteristicsandexpressionlevelsofeffluxpumpgenes
AT chanmingchin tigecyclineresistanceamongcarbapenemresistantklebsiellapneumoniaeclinicalcharacteristicsandexpressionlevelsofeffluxpumpgenes
AT huangliyueh tigecyclineresistanceamongcarbapenemresistantklebsiellapneumoniaeclinicalcharacteristicsandexpressionlevelsofeffluxpumpgenes
AT linyitsung tigecyclineresistanceamongcarbapenemresistantklebsiellapneumoniaeclinicalcharacteristicsandexpressionlevelsofeffluxpumpgenes
AT linjungchung tigecyclineresistanceamongcarbapenemresistantklebsiellapneumoniaeclinicalcharacteristicsandexpressionlevelsofeffluxpumpgenes
AT lupoliang tigecyclineresistanceamongcarbapenemresistantklebsiellapneumoniaeclinicalcharacteristicsandexpressionlevelsofeffluxpumpgenes
AT siulkristopher tigecyclineresistanceamongcarbapenemresistantklebsiellapneumoniaeclinicalcharacteristicsandexpressionlevelsofeffluxpumpgenes
AT changfengyee tigecyclineresistanceamongcarbapenemresistantklebsiellapneumoniaeclinicalcharacteristicsandexpressionlevelsofeffluxpumpgenes
AT yehkuoming tigecyclineresistanceamongcarbapenemresistantklebsiellapneumoniaeclinicalcharacteristicsandexpressionlevelsofeffluxpumpgenes